Dr. Chalasani is considered an authority in the fields of Non-Alcoholic Fatty Liver Disease (NAFLD) and Drug Induced Liver Injury (DILI), two highly significant public health problems.
Research: Non-Alcoholic Fatty Liver Disease (NAFLD), Drug Hepatotoxicity, Drug Metabolism
Clinical Interests: Acute and chronic liver disease, Fatty Liver, Non-Alcoholic Steatohepatitis (NASH), Drug Hepatotoxicity, Drug Metabolism
An important portion of his research focuses on clinical and translational aspects of hepatocellular carcinoma, one of the leading causes of cancer death worldwide.
Research: Nutrition and Physiology of Diabetes and Obesity